The natural history of isolated common femoral endarterectomy for chronic limb-threatening ischemia

Authors

Michael Chaney, Western Michigan University Homer Stryker, Kalamazoo, MI.
Gaurang Joshi, Advocate Health - Midwest
Jose L. Cataneo Serrato, Advocate Health - MidwestFollow
Mohammed Rashid, Advocate Health - MidwestFollow
Abraham Jacobs, Advocate Health - Midwest
Chad E. Jacobs, Advocate Health - MidwestFollow
John V. White, Advocate Health - MidwestFollow
Lewis B. Schwartz, Advocate Health - MidwestFollow
Rym El Khoury, Department of Surgery, Division of Vascular Surgery, NorthShore University Health System, Evanston, IL. Electronic address: rymelkhoury@gmail.com.

Recommended Citation

Chaney M, Joshi G, Cataneo Serrato JL, et al. The natural history of isolated common femoral endarterectomy for chronic limb-threatening ischemia. J Vasc Surg. 2024;80(5):1537-1542.e1. doi:10.1016/j.jvs.2024.05.050

Affiliations

Advocate Lutheran General Hospital

Abstract

Objective: Occlusive disease of the common femoral artery can generate profound lower extremity ischemia as the normal collateral pathways from the profunda to the superficial femoral artery cannot adequately develop. In patients with lifestyle-limiting claudication, isolated common femoral endarterectomy (CFE) is highly effective. Because CFE does not provide direct, in-line flow to the plantar arch, it has been felt to provide inadequate revascularization to patients with chronic limb-threatening ischemia (CLTI). The purpose of this retrospective clinical study was to report and assess the natural history of selected patients with CLTI treated with isolated CFE (without concomitant infrainguinal revascularization).

Methods: Consecutive CFEs performed in a large, urban hospital for CLTI between 2014 and 2021 were reviewed. Patient characteristics, limb, and anatomical stages using the Wound, Ischemia, foot Infection (WIfI) and Global Limb Anatomic Staging System were tabulated. Limb-specific and survival-related end points were analyzed.

Results: Fifty-eight patients presenting with CLTI underwent isolated CFE (mean age, 74 ± 10 years; 62% male, 90% current or prior smoker). Comorbidities included diabetes (52%), coronary artery disease (55%), congestive heart failure (22%), and end-stage renal failure on hemodialysis (5%). Patients presented with either rest pain (36%) or tissue loss (64%); the latter group exhibited advanced limb threat (68% in WIfI stage 3 or 4). The majority of patients had associated severe infrainguinal disease (50% Global Limb Anatomic Staging Systems 3). After a median follow-up of 17 months (range, 10-29 months), vascular reintervention was required in 7 patients (12%). One patient (2%) required major limb amputation after presentation in WIfI stage 4 (W3I3fI0). Indeed, WIfI stage 4 was a significant univariate predictor of the need for subsequent infrainguinal bypass (P = .034).

Conclusions: Isolated CFE as primary therapy in highly selected patients with CLTI was safe and effective. Index limb stage is predictive of the need for associated infrainguinal revascularization in this complex population.

Type

Article

PubMed ID

38823529